Mukka Proteins Ltd Extends Deadline for Acquisition of Vietnam Entity Due to Regulatory Hurdles
Mukka Proteins Limited has announced a delay in the execution of its acquisition of shares in Mukka Proteins Vietnam Co., Ltd. The company stated that the extension is necessary due to delays encountered while securing regulatory approvals within Vietnam.The acquisition pertains to acquiring and/or subscribing to shares in Mukka Proteins Vietnam Co., Ltd. for an amount not exceeding Rs 10,00,000, which is equivalent to 70% of the issued and paid-up share capital of the target company. The original announcement dates for this intended transaction were July 26, 2025, and December 31, 2025.
The initial expected date for the completion of the acquisition was June 30, 2026. However, citing delays in obtaining necessary regulatory approvals in Vietnam, Mukka Proteins Limited has revised this timeline. The updated date for the completion of the acquisition is December 31, 2026.
A summary of the acquisition details and the extension are provided below:
| Detail | Information |
|---|---|
| Acquiring Company | Mukka Proteins Limited |
| Target Company | Mukka Proteins Vietnam Co., Ltd. |
| Original Announcement Dates | July 26, 2025 and December 31, 2025 |
| Original Completion Date | June 30, 2026 |
| Revised Completion Date | December 31, 2026 |
| Reason for Delay | Delay in getting the regulatory approvals in Vietnam |
Mukka Proteins Limited confirmed that all requisite steps are actively being taken to address the delays. The company noted that the acquisition through share transfer will be completed in due course.
MUKKA Stock Price Movement
Shares of Mukka Proteins Limited are climbing to ₹23.99 as of 3:19 PM today, gaining 1.87% in live trading. The stock trades within the intraday range of ₹23.45 and ₹24.23, with 131,845 shares traded so far.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.